Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling, 2026: International consensus statement on behalf of the European Society for Immunodeficiencies/European Society for Blood and Marrow Transplantation–Inborn Errors Working Party and ERN-RITA

Journal of Allergy and Clinical Immunology 2026

View at publisher
Authors: Peter Olbrich, M. Fischer, A. Deyà-Martinez, C. Campos- Asensio, O. Neth, Jérôme Hadjadj, L.R. Forbes Satter, J.W. Leiding, T.R. Torgerson, S. Bakhtiar, S. Baris, R. Badolato
+35 more M. Bloomfield, E.P. Buddingh, L.M. Burroughs, S. Burns, M.A. Cooper, E. Crickx, S. Ehl, S. FARMAND, A.F. Freeman, L.I. Gonzalez-Granado, D. Hagin, L.G. Hanitsch, J. Hanzlíková, F. HAUCK, J. Ivorra-Cortés, J. Körholz, A. C. Lankester, T. R. (Ronan) Leahy, I. Meyts, J.D. Milner, Z. Nademi, J. Pachlopnik Schmid, M. Pergent, J. Prévot, J.G. Rivière, P. Roxo-Junior, C. Schuetz, M Slatter, P. Soler Palacín, K. Warnatz, P. Vítovcová, S.J. Vastert, B. Neven, M.H. Albert, C. Speckmann
DOI: 10.1016/j.jaci.2026.05.005
Cited by: 1
References: 108

Fields of Study & Subjects

Immunodeficiency and Autoimmune Disorders Cytokine Signaling Pathways and Interactions Autoimmune and Inflammatory Disorders Research

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Volume
158
Issue
2
Pages
598–609.e5
Publication date
27 May 2026
Language
EN